131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study
Crossref DOI link: https://doi.org/10.1007/s00259-015-3055-0
Published Online: 2015-04-22
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ko, Kuan-Yin
Kao, Chia-Hung
Lin, Cheng-Li
Huang, Wen-Sheng
Yen, Ruoh-Fang
Text and Data Mining valid from 2015-04-22